SCHEMBL3219636

SCHEMBL3219636

O=S(=O)(c1ccc(Cl)c(Cl)c1)N1CCC(N2CCOCC2)CC1

nearest known ligand 0.67

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.67
KDM4E B2RXH2 2/20 0.67
SMN1; SMN2 Q16637 1/20 0.67
HPGD P15428 1/20 0.63
KMT2A Q03164 4/20 0.54
MEN1 O00255 3/20 0.54
TSHR P16473 1/20 0.54
USP5 P45974 1/20 0.54
LMNA P02545 1/20 0.50
KDM2B Q8NHM5 1/20 0.49
MBTD1 Q05BQ5 1/20 0.49
L3MBTL3 Q96JM7 1/20 0.49
MAPK1 P28482 1/20 0.49
CASP3 P42574 1/20 0.48
CASP7 P55210 1/20 0.48
HSD11B1 P28845 1/20 0.48
GAA P10253 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3218831 0.89 ALDH1A1 (0.56) ALDH1A1KDM4ESMN1; SMN2HPGDKMT2A
SCHEMBL17007430 0.84 DHCR7 (0.64) ALDH1A1KDM4EKMT2AMEN1LMNA
SCHEMBL165947 0.81 ALDH1A1 (0.67) ALDH1A1KDM4ESMN1; SMN2HPGDKMT2A
SCHEMBL164996 0.77 ALDH1A1 (0.62) ALDH1A1KDM4ESMN1; SMN2HPGDKMT2A
SCHEMBL22233113 0.77 ALDH1A1 (0.57) ALDH1A1KDM4ESMN1; SMN2HPGDKMT2A
SCHEMBL14847757 0.77 RAB9A (0.55) KDM4ETSHRLMNAMAPK1HSD11B1
SCHEMBL2962711 0.77 CCR1 (0.60) ALDH1A1KDM4ESMN1; SMN2HPGDKMT2A
SCHEMBL21958453 0.75 ALDH1A1 (0.55) ALDH1A1KDM4ESMN1; SMN2HPGDKMT2A
SCHEMBL17014228 0.74 SMN1; SMN2 (0.59) ALDH1A1KDM4ESMN1; SMN2HPGDKMT2A
SCHEMBL14829559 0.74 RAB9A (0.52) KDM4EKMT2AMEN1TSHRLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100029648-A1 11-Beta HSD1 Inhibitors XIANG JASON SHAOYUN 2010-02-04 US disclosed
US-7632838-B2 11-beta HSD1 inhibitors WYETH (US) 2009-12-15 US disclosed
US-20070219198-A1 11-Beta HSD 1 inhibitors WYETH (US) 2007-09-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029648-A1 11-Beta HSD1 Inhibitors HSD11B1, HSD3B1, HSD11B2 ALDH1A1 116/4885KDM4E 1296/4885SMN1; SMN2 3575/4885
US-20070219198-A1 11-Beta HSD 1 inhibitors HSD11B1, HSD11B2, HSD3B1 ALDH1A1 123/4885KDM4E 1360/4885SMN1; SMN2 3686/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.